Literature DB >> 19796452

Disseminated Cryptococcus neoformans var. grubii infections in intensive care units.

Y-M Chuang1, S C Ku, S J Liaw, S C Wu, Y C Ho, C J Yu, P R Hsueh.   

Abstract

A retrospective study of clinical characteristics, outcome and prognostic factors of patients with cryptococcosis was undertaken in intensive care units (ICUs) of a medical centre for the period 2000-2005. Twenty-six patients with Cryptococcus neoformans var. grubii infection were identified (16 males, median age 58 years). The most frequent underlying diseases were liver cirrhosis (38.5%), diabetes mellitus (26.9%) and HIV infection (19.2%). The most frequently identified sites of infection were blood (61.5%), cerebrospinal fluid (38.5%) and airways (34.6%). The mean Acute Physiologic and Chronic Health Evaluation II score at ICU admission was 22.46. The ICU mortality rate in these patients was 73.1% (19/26) and there were a further two mortalities recorded after discharge from ICU, reaching a total mortality rate of 80.8% (21/26). Patients with ICU survival >2 weeks had lower rates of HIV infection (P=0.004), less use of inotropic agents during ICU stay (P<0.001) and lower white blood cell counts (P=0.01). After adjusting for clinical variables in the multivariate Cox regression model, diabetes and cryptococcal infection after ICU admission were independent predictors of good long-term prognosis (P=0.015) and HIV infectious status was associated with poor outcome (P=0.012).

Entities:  

Mesh:

Year:  2009        PMID: 19796452     DOI: 10.1017/S0950268809990926

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  5 in total

1.  Cryptococcosis and cryptococcal meningitis: New predictors and clinical outcomes at a United States academic medical centre.

Authors:  Bahar H Kashef Hamadani; Carlos Franco-Paredes; Bruce McCollister; Leland Shapiro; J David Beckham; Andrés F Henao-Martínez
Journal:  Mycoses       Date:  2018-01-23       Impact factor: 4.377

2.  Insights on the genotype distribution among Cryptococcus neoformans and C. gattii Portuguese clinical isolates.

Authors:  A P Maduro; K Mansinho; F Teles; I Silva; W Meyer; M L Martins; J Inácio
Journal:  Curr Microbiol       Date:  2014-02       Impact factor: 2.188

3.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

4.  Risk Factors for Cryptococcal Meningitis: A Single United States Center Experience.

Authors:  Andrés F Henao-Martínez; Lilyana Gross; Bryan Mcnair; Bruce McCollister; Kristen DeSanto; Jose G Montoya; Leland Shapiro; J David Beckham
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

5.  Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis.

Authors:  Delio José Mora; Laila Rigolin Fortunato; Leonardo Eurípedes Andrade-Silva; Kennio Ferreira-Paim; Ivonete Helena Rocha; Rakel Rocha Vasconcelos; David Nascimento Silva-Teixeira; Gabriel Antonio Nogueira Nascentes; Mario León Silva-Vergara
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.